Deutsche Bank’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,016
Closed -$115K 4218
2022
Q1
$115K Sell
1,016
-120
-11% -$13.9K ﹤0.01% 3532
2021
Q4
$109K Buy
1,136
+59
+5% +$5.31K ﹤0.01% 3669
2021
Q3
$95K Buy
1,077
+156
+17% +$15.4K ﹤0.01% 3919
2021
Q2
$113K Buy
921
+564
+158% +$78K ﹤0.01% 4087
2021
Q1
$57K Sell
357
-34
-9% -$5.77K ﹤0.01% 4198
2020
Q4
$60K Buy
391
+112
+40% +$20.1K ﹤0.01% 4067
2020
Q3
$52K Buy
279
+121
+77% +$19.8K ﹤0.01% 3874
2020
Q2
$19K Buy
+158
New +$16.1K ﹤0.01% 4052
2020
Q1
Sell
-40
Closed -$3K 4547
2019
Q4
$3K Buy
+40
New +$3.33K ﹤0.01% 4752
2019
Q3
Sell
-19
Closed -$2K 5076
2019
Q2
$2K Sell
19
-75
-80% -$9.85K ﹤0.01% 5177
2019
Q1
$6K Sell
94
-5
-5% -$439 ﹤0.01% 4999
2018
Q4
$6K Sell
99
-276
-74% -$32.3K ﹤0.01% 4950
2018
Q3
$41K Buy
375
+200
+114% +$522K ﹤0.01% 4769
2018
Q2
$481K Buy
175
+162
+1,246% +$374K ﹤0.01% 3865
2018
Q1
$35K Buy
13
+12
+1,200% +$27.5K ﹤0.01% 4863
2017
Q4
$3K Buy
+1
New +$2.21K ﹤0.01% 4893
2017
Q3
Hold
0
4967
2017
Q2
Sell
-14
Closed -$18.7K 5014
2017
Q1
$22K Sell
14
-19
-58% -$34.8K ﹤0.01% 4478
2016
Q4
$55K Buy
33
+23
+230% +$50.4K ﹤0.01% 4327
2016
Q3
$23K Sell
10
-8
-44% -$19.7K ﹤0.01% 4492
2016
Q2
$45K Buy
18
+5
+38% +$16.4K ﹤0.01% 4455
2016
Q1
$47K Hold
13
﹤0.01% 4338
2015
Q4
$60K Sell
13
-14
-52% -$45.7K ﹤0.01% 4313
2015
Q3
$42K Sell
27
-258
-91% -$1.29M ﹤0.01% 4530
2015
Q2
$2.41M Buy
285
+37
+15% +$353K ﹤0.01% 2309
2015
Q1
$2.48M Sell
248
-8
-3% -$73.5K ﹤0.01% 2284
2014
Q4
$2.55M Buy
+256
New +$1.97M ﹤0.01% 2482
2014
Q3
Hold
0
5757
2014
Q2
Hold
0
5949

Other funds holding IMUX

Deutsche Bank's IMUX Position: Q2 2022 in Review

Deutsche Bank sold out of Immunic (IMUX) in Q2 2022, closing a stake of 1,016 shares — an estimated $115K sold.

Deutsche Bank first reported a position in IMUX in Q4 2014 and held it in 26 quarters. The position peaked at $2.55M in Q4 2014. 72 funds tracked by Wall St. Rank hold IMUX as of Q2 2022.

  • Deutsche Bank reported no remaining Immunic position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 1,016 Immunic shares in Q2 2022, an estimated $115K.
  • Deutsche Bank first reported a position in Immunic in Q4 2014 and held it in 26 quarters.
  • Deutsche Bank's Immunic position peaked at $2.55M in Q4 2014.
  • 72 funds tracked by Wall St. Rank held Immunic as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.